Macrophage-associated mitochondrial transfer is linked to daunorubicin tolerance in AML models
Abstract
Abstract Interactions between acute myeloid leukaemia (AML) cells and the bone marrow microenvironment can reduce responses to chemotherapy. Macrophages are abundant in AML bone marrow, but how macrophage-associated mitochondrial trafficking relates to drug tolerance remains incompletely defined. Using AML cell lines, primary AML specimens and monocyte-, iPSC- and mouse bone marrow-derived macrophage models, we found that M-CSF-differentiated macrophages attenuated daunorubicin-induced AML apoptosis, with the strongest protection during direct co-culture. AML cells acquired macrophage-derived MitoTracker Deep Red signal, which increased with daunorubicin and was reduced by transwell separation, cytochalasin B and LIMK inhibition. Cross-species co-culture provided orthogonal molecular support through species-specific measurement of murine mitochondrial DNA, with murine nuclear DNA measured in parallel as a control. Macrophage co-culture was also associated with increased AML respiratory capacity and reduced reactive oxygen species. Exploratory proteomic analysis and interrogation of public transcriptomic datasets nominated RHOC/LIMK/cofilin signalling for follow-up, while TH-257 and metformin reduced the transfer-associated signal and macrophage chemoprotection. These findings support an association between acquisition of macrophage-derived mitochondrial material and daunorubicin tolerance in AML models and identify LIMK-dependent actin regulation as a candidate mechanism for further investigation.
// Source
Authors: Ebubechukwu Nwarunma, Katerina E. Miari, Αθανασία Παπαδοπούλου, Stefan Corradini, Glen Watt, Samantha Hurwitz, Tatiana Fourfouris, Ki Jun Lee, Xenia Bubnova, Rebecca Briggs, Carl S. Goodyear, Theodoros Simakou, Marcus Doohan, Lucy MacDonald, Aziza Elmesmari, Mariola Kurowska‐Stolarska, Timothy J. Humpton, Victoria L. Campbell, Lesley M. Forrester, K. Mills, Katrina Lappin, Valerie Anne Ferro, Yong Mi Kim, Helen Wheadon, Mark T.S. Williams
Institutions: Queen's University Belfast, University of Glasgow, University of Edinburgh, Children's Hospital Los Angeles, Glasgow Caledonian University, University of Strathclyde, MRC Centre for Regenerative Medicine, Cancer Research UK Scotland Institute, Western General Hospital, The Northern Ireland Cancer Centre